Ikponmwosa Iyamu, MD
Vascular & Interventional Radiology · Fort Worth, TXNPI 1679891980
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,230 of the $9,004 with a category attached, or 69.2%. Cook Incorporated accounts for 69.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $6,777 and has fallen 90.5% since, to $645 in 2025.
Across 97 payments — averaging $92.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$6K
- Stryker$582
- Sirtex Medical Inc$572
- Cook Medical LLC$471
- Angiodynamics, Inc.$263
- W. L. Gore & Associates, Inc.$219
- plus $667 from 10 others
What the payments were for
- Speaking & faculty fees$6,23069%
- Food & beverage$2,77431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 1 | $6,230 |
| Stryker | 21 | $582 |
| Sirtex Medical Inc | 12 | $572 |
| Cook Medical LLC | 20 | $471 |
| Angiodynamics, Inc. | 10 | $263 |
| W. L. Gore & Associates, Inc. | 7 | $219 |
| Penumbra, Inc. | 5 | $179 |
| Boston Scientific | 3 | $93 |
| Bard Peripheral Vascular, Inc. | 3 | $87 |
| Argon Medical Devices, Inc. | 4 | $86 |
| Shockwave Medical, Inc | 2 | $67 |
| Medtronic(2 entities) | 3 | $49 |
| Inari Medical, Inc. | 2 | $36 |
| Biocompatibles, Inc. | 2 | $34 |
| Trisalus Life Sciences, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,004 in reported general payments places this provider in the 75th percentile of 299 vascular & interventional radiology providers in Texas.
See all vascular & interventional radiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $116 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Fort Worth
- Brice AndringFort Worth$63K
- Rakesh AhujaFort Worth$24K
- Curtis MitchellFort Worth$19K
- Orlando DiazHouston$611K
- Rahul ShethHouston$410K
- Miguel MonteroHouston$386K
- Joshua KubanHouston$301K
- Peiman HabibollahiHouston$254K
- Ahmed Abdel AalHouston$147K
- Varshana GurusamyHouston$141K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.